Please find enclosed herewith copy of proceeding of 31st Annual General Meeting of the company for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd held its 31st AGM on 31st December 2025 at its registered office in Jhajjar, Haryana, from 9:00 AM to 9:30 AM, chaired by Managing Director Mr. Yogesh Agrawal. Six resolutions were put to shareholders for approval via remote e-voting (28–30 December 2025) and ballot paper at the meeting. Ordinary resolutions included adoption of audited financial statements for FY ended 31 March 2025, re-appointment of Ms. Parul Agrawal (retiring by rotation), appointment of secretarial auditors for five years, and regularization of Mr. Yogainder Kumar Gupta as Independent Director. Special resolutions covered the re-appointment of Mr. Yogesh Agrawal as Chairman and Managing Director for five years effective 7 September 2025, and alteration of the Object Clause of the Memorandum of Association. The meeting concluded after polling was completed, with a scrutinizer overseeing the ballot process.
Routine procedural filing — no immediate price impact expected. Shareholders should note the proposed MOA object clause change (special resolution) and the MD's fresh 5-year re-appointment, both of which signal continuity in management and potential expansion in business activities.